Early detection and molecular characterization of disease progression are persistent challenges in modern medicine. Although genomic and transcriptomic profiling of tissue lesions and precursors has ...
To study biological processes, scientists often take snapshots of the molecules in cells, such as proteins and nucleotides, at specific points in time. In spatial biology, they can leverage molecular ...
Hello and welcome to this podcast from Nature Research Custom Media and Leica Microsystems. I’m science journalist Izzie Clarke, and in this episode we explore an innovative technique that shows where ...
As the field of proteomics continues to advance, scientists are using new methods to answer longstanding questions about rare diseases. One such disease is α-1-antitrypsin deficiency (AATD), a ...
When Matthew Padula was diagnosed with a rare bladder cancer in 2020, he knew there was a challenging road ahead of him. As a researcher at the University of Technology Sydney, his first instinct was ...
Seer, Inc. (Nasdaq: SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced its participation at the 2026 American Society for Mass Spectrometry (ASMS) Annual ...
Thierry Nordmann (left) is a clinician-scientist and dermatologist with a focus on inflammatory cutaneous disorders. He completed his PhD after his medical studies, investigating anti-inflammatory ...
Robust, Unbiased and Affordable 4D-Proteomics™ for Highest-Specificity Protein IDs & Quant Enables High-Fidelity Large-Scale Plasma Proteomics Typical Sequence Coverage >10 Peptides/protein and >100k ...
Those hoping to uncover new science may feel disheartened if they struggle with inadequate tools and doubt that more capable tools are within reach. Until recently, such was the case in proteomics.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results